Industry Wants Greater Transparency in FDA Meeting Decisions
Earlier this year, the United States Food and Drug Administration (FDA) sought comments on the best practices for meeting management, holding a workshop to fulfill a commitment in the Prescription Drug User Fee Act (PDUFA VII). In the workshop, FDA aimed to understand issues related to meeting requests, efficient time management, finalizing meeting…
Read More...